Hope, confusion in hunt for ovarian cancer tests

Does a test that promises to find ovarian cancer sooner really do so? Could other tests nearing the market prolong survival by getting patients the right care faster? A race is on for blood tests to better detect this intractable killer, but the Food and Drug Administration is probing whether to crack down on the first one to sell.

Hope, confusion in hunt for ovarian cancer tests

WASHINGTON -- Does a test that promises to find ovarian cancer sooner really do so? Could other tests nearing the market prolong survival by getting patients the right care faster?

Rethinking the War on Cancer

After billions spent on research and decades of hit-or-miss treatments, it's time to rethink the war on cancer.

Scientists Identify Genetic Contributor to Colorectal Cancer Risk (American Cancer Society)

American Cancer Society - Researchers at Ohio State University Comprehensive Cancer Center and Northwestern University's Cancer Genetics Program have found a definitive link between an inherited genetic variation and colorectal cancer risk. The variation, which occurs on a gene known as TGFBR1, significantly increases a person's lifetime risk of getting the disease.

British Sanger Institute to study personalised cancer treatments

Scientists have begun a groundbreaking study of cancer that will “mix and match” tumours with drugs to develop personalised therapies for patients.

The Truth About Cell Phones and Cancer (LiveScience.com)

LiveScience.com - Ronald Herberman, director of the University of Pittsburgh Cancer Institute, shocked just about all law-abiding scientists (abiding by laws of physics, that is) with his warning last week to his faculty and staff that cell phones might pose a cancer risk.